Episode Details

Back to Episodes
Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals

Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals

Episode 26022 Published 5 months, 3 weeks ago
Description

On this episode of BioTech Nation: how Syndax Pharmaceuticals got two new drugs approved in the last two years, for the treatment of acute myeloid leukemia and graft vs. host disease in both adults and children. CEO Michael Metzger talks to Moira about Syndax's approach to getting the drugs across the finish line, and how they've now set their sights on additional indications and cancer therapies. 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us